Quantum Biopharma Ltd. Files 6-K, Incorporates Press Release
Ticker: QNTM · Form: 6-K · Filed: Sep 9, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Sep 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: procedural, registration-statement, press-release
TL;DR
Quantum Biopharma filed a 6-K to add a press release to its F-3. No new money or news, just paperwork.
AI Summary
On September 6, 2024, Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K to incorporate by reference a press release into its existing Registration Statement on Form F-3 (SEC File No. 333-276264). This filing does not contain new financial information but serves to update ongoing registration statements.
Why It Matters
This filing is procedural, incorporating a press release into an existing F-3 registration statement, which is relevant for ongoing capital raising activities or disclosures.
Risk Assessment
Risk Level: low — This is a routine procedural filing that incorporates a press release into an existing registration statement, with no new financial or operational information presented.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- September 6, 2024 (date) — Date of press release
- Form F-3 (document) — Registration statement into which the press release is incorporated
- SEC File No. 333-276264 (document) — SEC file number for the Form F-3
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to incorporate by reference a press release issued by Quantum Biopharma Ltd. on September 6, 2024, into the company's existing Registration Statement on Form F-3 (SEC File No. 333-276264).
Does this filing contain new financial information?
No, this filing does not appear to contain new financial information; it is primarily a procedural filing to incorporate a previously issued press release into an ongoing registration statement.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
What is the SEC file number for the Registration Statement being referenced?
The SEC file number for the Registration Statement on Form F-3 being referenced is 333-276264.
When was the press release incorporated by reference issued?
The press release that is incorporated by reference was issued on September 6, 2024.
Filing Stats: 239 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2024-09-06 21:22:51
Filing Documents
- fsd_6k.htm (6-K) — 11KB
- fsd_ex991.htm (EX-99.1) — 27KB
- 0001654954-24-011594.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: September 6, 2024 By: /s/ Donal Carroll Donal Carroll, Chief Financial Officer 2 EXHIBIT INDEX Exhibit Description Exhibit 99.1 Press Release dated September 6, 2024 3